Trial intelligence / Profile preview

Topical cyclosporine mucoadhesive gel for oral lichen planus

2017-000791-29Phase 2Terminated

Sponsor
Clínica Universidad de Navarra
Start
Jun 2017
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of cyclosporine in oral lichen planus (OLP) (3 arms), sponsored by Clínica Universidad de Navarra. Primary endpoint: Extent of mucosal involvement. Started Jun 2017; status: terminated.

02

Drugs

cyclosporine
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on 2017-000791-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-000791-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call